Eric Martsolf

Eric Martsolf

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.
  • Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.
  • Democratic Rep. Jasmine Crockett faces allegations of staff abuse and a focus on building an online influencer persona rather than legislative duties.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Eric Martsolf